Skip to main content
. 2018 Aug 30;2018:9695628. doi: 10.1155/2018/9695628

Table 1.

Clinical observations in ferrets after vaccination with monovalent B-LAIV.

Group B/Vic LAIV (groups 1-2) B/Yam LAIV (groups 3-4) Intact animals (group 7)
Day Day 0 Day 1 Day 2 Day 3 Day 0 Day 1 Day 2 Day 3 Day 0 Day 1 Day 2 Day 3
Body temperature (°C) 38.4 38.3 38.7 38.8 38.7 38.8 38.9 38.8 38.5 38.7 38.6 38.7
Activity [group Median (Q1-Q3)] 3.0 (3.0-3.0) 2.5 (1.0-3.0) 2.5 (1.0-3.0) 3.0 (3.0-3.0) 3.0 (3.0-3.0) 1.5 (0.0-2.0) 2.0 (2.0-2.0) 2.5 (2.0-3.0) 3.0 (3.0-3.0) 3.0 (3.0-3.0) 3.0 (3.0-3.0) 3.0 (3.0-3.0)
Respiratory symptoms [group Median (Q1-Q3)] 0.0 (0.0-0.0) 0.51 (0.0-1.0) 0.51 (0.0-1.0) 0.51 (0.0-1.0) 0.0 (0.0-0.0) 1.01 (1.0-1.0) 1.01 (1.0-1.0) 1.01 (0.0-1.0) 0.0 (0.0-0.0) 0.0 (0.0-0.0) 0.0 (0.0-0.0) 0.0 (0.0-0.0)

Abbreviations are used here and in Tables 25 and Figures 1 and 2: B/Yam LAIV, monovalent LAIV based on B/60/Phuket/2013/26 (B/Yamagata lineage); B/Vic LAIV, monovalent LAIV based on B/60/Brisbane/2008/83 (B/Victoria lineage); B/Yam WT, B/Phuket/3073/2013 wild type virus (B/Yamagata lineage); B/Vic WT, B/Brisbane/60/2008 wild-type virus (B/Victoria lineage). Statistically significant differences: 1median test between groups, p≤0.05, post hoc Dunnett test, p≤0.05 (versus intact group).